Pfizer Says JAKs Have Their Place Despite Xeljanz Safety Issues

 
• By Jessica Merrill
  
Pillars with vintage style filter
Pfizer says its JAK growth pillar remains strong • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business